Programmable care rise enables health systems to deliver proactive, continuous care using AI and real-time data across patient journeys.

Principal Scientist Anders Cai Holm Hansen explains how CDMO AGC Biologics uses its global, single-use network and a strategy ...

Objective SLE is a systemic autoimmune disease in which the complement system plays a key pathogenic role, yet the ...

SANTA MONICA - The City Council has authorized a sweeping reassessment of how the city addresses homelessness and affordable ...

First patient dosed in Opti-GAIN, a first-in-human Phase I/II clinical trial of CTx001 in Geographic Atrophy secondary to AMD CTx001 is an investigational AAV-based gene therapy designed to deliver ...

Multi-omics profiling of residual cancer burden after neoadjuvant hormonal therapy guides subtype-directed treatment in high-risk and locally advanced prostate cancer. Predictive associations between ...

Boeing engineers Kevin Kwak (foreground) and Klaus Okkelberg confer with fellow team members Arvel Chappell III and Andrew Riha (both on-screen), who worked together to prototype a large language ...

Ocugen has reported preliminary phase 2 data on its eye disease gene therapy, providing more evidence that the candidate may outperform existing treatments from Apellis Pharmaceuticals and Astellas ...

Cedars-Sinai investigators have identified a genetic variant that increases people's risk of developing perianal Crohn's disease, the most debilitating manifestation of Crohn's disease. Science X ...

In 2018, the California state legislature set the goal of reaching net-zero carbon emissions by 2045 in the California Climate Crisis Act. In September of 2025, a team of Stanford researchers ...

SAN FRANCISCO -- The investigational complement-targeting agent claseprubart was safe and led to significant improvements in generalized myasthenia gravis (MG), the phase II MaGic trial showed. The ...

A breast cancer diagnosis should trigger immediate action. But for many patients, the journey to treatment begins with delays, often caused by outdated prior authorization (PA) processes. Designed to ...